Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

St. Jude's Biocor acquisition expands tissue heart valve stable.

This article was originally published in The Gray Sheet

Executive Summary

ST. JUDE EUROPEAN SALES FORCE ADDING BIOCOR TISSUE VALVES to its product catalog via the Sept. 23 acquisition of Belo Horizonte, Brazil-based Biocor Industria E Pesquisas Ltd. St. Jude, with a direct sales presence in 14 European countries, plans to switch Biocor's products from existing distributors to its own direct sales force in Europe over the next three to four months.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT006802

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel